Aveanna Healthcare Holdings Inc.

NMS: AVAH
Live Quote

📈 ZcoreAI Score

Our AI model analyzes Aveanna Healthcare Holdings Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get AVAH Z-Score →

About Aveanna Healthcare Holdings Inc.

Healthcare Medical Care Facilities
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

📊 Fundamental Analysis

Aveanna Healthcare Holdings Inc. demonstrates a profit margin of 9.2%, which is below the sector average, suggesting competitive pressure.

The company recently reported 27.4% revenue growth, which is well above average for the Healthcare sector.

Return on Equity (ROE) is 615.7%, which reflects exceptional capital efficiency.

At a current price of $6.22, AVAH currently sits at the 38th percentile of its 52-week range (Range: $3.73 - $10.32).

💰 Valuation Insight

AVAH trades at a 76.3% discount (PE: 5.92), which may represent a value opportunity given the sector average of 25.00. Analysts anticipate some earnings pressure, with a higher forward PE.

🏥 Financial Health

🔴 Profit Margin Weak
🔴 Debt/Equity Elevated
Revenue Growth Excellent
Return on Equity Excellent
🔴 Beta (Risk) High Volatility

Key Financials

Market Cap
$1.35B
Trailing P/E
5.92
Forward P/E
8.90
Beta (5Y)
2.09
52W High
$10.32
52W Low
$3.73
Avg Volume
1.22M
Day High
Day Low
Get AVAH Z-Score on Dashboard 🚀